Ovid Application Error
Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient. Romero-Laorden, N.; Pineiro-Yanez, E.; Gutierrez-Pecharroman, A.; Pacheco, M. I.; Calvo, E.; Al-Shahrour, F.; Castro, E.; Olmos, D. [Letter] Annals of Oncology. 28(5):1158-1159, May 01, 2017.
(Format: HTML)